Imiglucerase in the treatment of Gaucher disease: a history and perspective

The scientific and therapeutic development of imiglucerase (Cerezyme(®)) by the Genzyme Corporation is a paradigm case for a critical examination of current trends in biotechnology. In this article the authors argue that contemporary interest in treatments for rare diseases by major pharmaceutical c...

Descripción completa

Detalles Bibliográficos
Autores principales: Deegan, Patrick B, Cox, Timothy M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340106/
https://www.ncbi.nlm.nih.gov/pubmed/22563238
http://dx.doi.org/10.2147/DDDT.S14395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340106/
https://www.ncbi.nlm.nih.gov/pubmed/22563238
http://dx.doi.org/10.2147/DDDT.S14395

Ejemplares similares